Related Experiment Video
Updated: May 30, 2026
09:52
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma.
Bojie Dai1, X Frank Zhao, Krystyna Mazan-Mamczarz
1University of Maryland, Marlene & Stewart Greenebaum Cancer Center, Department of Medicine, Baltimore, Maryland 21201, USA.
Nature Communications
|July 21, 2011
Summary
This study reveals a new link between ERK1/2 and CHK2 in diffuse large B-cell lymphoma (DLBCL). Targeting both ERK and CHK2 may improve DLBCL cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Non-Hodgkin lymphoma involves distinct oncogenic signaling pathways.
- ERK1/2 signaling impacts gene expression and protein function via phosphorylation.
- CHK2 is a critical protein kinase in the DNA damage response pathway.
Purpose of the Study:
- To investigate a novel molecular relationship between ERK1/2 and CHK2.
- To explore the potential of combined therapeutic targeting of ERK and CHK2 in DLBCL.
Main Methods:
- Demonstration of ERK1/2 and CHK2 co-localization and overexpression in DLBCL.
- Assessment of the physical interaction between ERK and CHK2, dependent on CHK2 phosphorylation.
- Evaluation of concurrent ERK and CHK2 inhibition in DLBCL models.
Main Results:
- First report of ERK1/2 and CHK2 co-localization and overexpression in DLBCL.
- Established a physical interaction between ERK and CHK2, regulated by phosphorylated CHK2 (pT68).
- Concurrent inhibition of ERK and CHK2 demonstrated enhanced anti-tumor activity in DLBCL xenografts and primary cells.
Conclusions:
- Identified a functional interaction between ERK1/2 and CHK2 in DLBCL.
- Supports the combined therapeutic targeting of ERK and CHK2 as a potential strategy for human DLBCL treatment.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...